Questions about palivizumab (Synagis)

Pediatrics. 1999 Feb;103(2):535; author reply 535-6.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Canada
  • Cost-Benefit Analysis
  • Humans
  • Infant
  • Length of Stay
  • Palivizumab
  • Respiratory Syncytial Virus Infections / economics
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Respiratory Syncytial Viruses*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Palivizumab